BackgroundCheck.run
Search For

Lillian Chiang, 533224 Tice Creek Dr UNIT 12, Walnut Creek, CA 94595

Lillian Chiang Phones & Addresses

3224 Tice Creek Dr APT 12, Walnut Creek, CA 94595   

Oakland, CA   

Marina del Rey, CA   

100 Winston Dr, Cliffside Park, NJ 07010    201-8863197   

100 Winston Dr #4MN, Cliffside Park, NJ 07010    201-2249248   

New York, NY   

Los Angeles, CA   

Wilkes Barre, PA   

Lancaster, PA   

280 Caldecott Ln UNIT 201, Oakland, CA 94618    201-2249248   

Work

Address: 2222 Bancroft Way, Berkeley, CA 94720 Specialities: Psychologist

Languages

English

Mentions for Lillian Chiang

Career records & work history

Medicine Doctors

Lillian Chiang Photo 1

Dr. Lillian Chiang, Berkeley CA - PHD

Specialties:
Counseling
Psychology
Address:
2222 Bancroft Way Suite 4300, Berkeley, CA 94720
510-6422709 (Phone) 510-6422368 (Fax)
Languages:
English
Lillian Chiang Photo 2

Lillian Chiang, Berkeley CA

Specialties:
Psychologist
Address:
2222 Bancroft Way, Berkeley, CA 94720

Lillian Chiang resumes & CV records

Resumes

Lillian Chiang Photo 13

Lillian Chiang

Location:
San Francisco Bay Area
Industry:
Banking
Lillian Chiang Photo 14

Lillian Chiang

Location:
San Francisco Bay Area
Industry:
Banking
Lillian Chiang Photo 15

Finance Manager At The Clorox Company

Location:
San Francisco Bay Area
Industry:
Consumer Goods

Publications & IP owners

Us Patents

Neuronal Cell Death Associated Molecules And Uses Therefor

US Patent:
2002011, Aug 22, 2002
Filed:
Sep 18, 2001
Appl. No.:
09/954973
Inventors:
Lillian Chiang - Edison NJ, US
Andrew Wood - Newtown PA, US
Lily Shiue - Santa Cruz CA, US
Lorayne Jenkins - Monmouth Junction NJ, US
Assignee:
Millennium Pharmaceuticals, Inc. - Cambridge MA
International Classification:
C12N009/64
C07H021/04
C12P021/02
C12N005/06
US Classification:
435/226000, 435/069100, 435/325000, 435/320100, 536/023200
Abstract:
The invention provides isolated nucleic acids molecules, designated CDAP nucleic acid molecules, which are differentially expressed in cells undergoing programmed cell death. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing CDAP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a CDAP gene has been introduced or disrupted. The invention still further provides isolated CDAP proteins, fusion proteins, antigenic peptides and anti-CDAP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

Narc10 And Narc16, Programmed Cell Death-Associated Molecules And Uses Thereof

US Patent:
2003016, Sep 4, 2003
Filed:
Jan 15, 2002
Appl. No.:
10/047855
Inventors:
Lillian Chiang - Edison NJ, US
Assignee:
Millennium Pharmaceuticals, Inc.
International Classification:
C12Q001/68
C07H021/04
C12N009/64
C12P021/02
C12N005/06
US Classification:
435/006000, 435/069100, 435/226000, 435/320100, 435/325000, 536/023200
Abstract:
Novel programmed cell death-like polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated, full-length programmed cell death-related polypeptides, the invention further provides isolated programmed cell death-related fusion proteins, antigenic peptides, and anti-programmed cell death-related antibodies. The invention also provides programmed cell death-related nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a programmed cell death-related gene has been introduced or disrupted. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.